HOME › DRUGS › UMECLIDINIUM BROMIDE;VILANTEROL
ACTIVE SUBSTANCE / INN

UMECLIDINIUM BROMIDE;VILANTEROL

Brand name(s): Anoro Ellipta (previously Anoro), Laventair Ellipta (previously Laventair)
EMA LISTED
AUTHORISED
Pulmonary Disease, Chronic Obstructive
ACTIVE SUBSTANCE
Umeclidinium Bromide;Vilanterol
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Laventair Ellipta (previously Laventair)GlaxoSmithKline Trading Services LimitedAuthorised08/05/2014Pulmonary Disease, Chronic Obstructive
Anoro Ellipta (previously Anoro)GlaxoSmithKline Trading Services LimitedAuthorised08/05/2014Pulmonary Disease, Chronic Obstructive

FULL INTELLIGENCE ON UMECLIDINIUM BROMIDE;VILANTEROL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →